Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Masson Kristina sold 1,713 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Masson Kristina (Director, EVP - Business Operations) sold 1,713 Acrivon Therapeutics, Inc. shares at US$2.01 for US$3,443, leaving 385,859 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 1,713 shares
- Price
- US$2.01
- Value
- US$3,443
- Holding after
- 385,859 shares (held indirectly)
- Trading plan
- No
- Role
- Director, EVP - Business Operations
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 1,229 | US$2.01 | 2,244,088 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 484 | US$2.01 | 385,859 | Indirect |
Source
Related
- Acrivon Therapeutics, Inc.
- Masson Kristina
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Masson Kristina · May 26, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026